Diaz Martinez JP, Aubry de Maraumont T, Natty Sanchez E, Camacho Cordero LM, et al. Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico. PLoS One 2025;20:e0299673.
PMID: 39919094